SCHEMBL8389166

SCHEMBL8389166

COc1c(Br)cc(C2=C(c3ccc(S(N)(=O)=O)cc3)CC3(CC3)C2)cc1Br

nearest known ligand 0.76

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 19/20 0.76
PTGS1 P23219 15/20 0.76
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8389357 0.90 PTGS2 (0.76) PTGS2PTGS1
SCHEMBL8387445 0.87 PTGS2 (0.76) PTGS2PTGS1CA12CA1CA2
SCHEMBL8389067 0.86 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL8383976 0.86 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8389346 0.86 PTGS2 (0.76) PTGS2PTGS1
SCHEMBL8385093 0.86 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8387271 0.85 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL8385281 0.85 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL8387685 0.83 PTGS2 (0.72) PTGS2PTGS1CA12CA2CA9
SCHEMBL8384332 0.82 PTGS2 (1.00) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743938-B1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 1999-04-21 EP disclosed
EP-0743938-A1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-27 EP disclosed
WO-1995021817-A1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-08-17 WO disclosed
US-5393790-A Diphenyl- or phenyl/pyridyl-substituted spiroheptenes, -octenes,-nonenes or -decenes; cyclooxygenase II inhibitors; side effect reduction; antipyretics; antiarthritic agents G.D. SEARLE & CO. (US) 1995-02-28 US disclosed